Mario Miguel Barbosa Rengifo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mario Miguel Barbosa Rengifo has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Juan Esteban Gómez-Mesa
Departamento de Cardiología, Fundación Valle del Lili, Cali, Colombia
5 shared publications - Andrea Valencia-Orozco
Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali 760032, Colombia
3 shared publications - Juan Andrés Muñoz-Ordoñez
Facultad de ciencias de la salud Universidad Icesi Cali Colombia
3 shared publications - Valeria Azcarate-Rodriguez
Facultad de ciencias de la salud Universidad Icesi Cali Colombia
3 shared publications - Alberto Federico García
Servicio de Cirugía de Trauma y Emergencias Fundación Valle del Lili Cali Colombia
2 shared publications - Alexander Romero
Servicio de Cardiología, Hospital Santo Tomas Ciudad de Panamá Panamá
2 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by Springer Nature in World Journal of Emergency Surgery
Run or Rush: a practical approach for diagnostic and therapeutic decision-making in patients with trauma and hemodynamic instability
- 19 November 2026
- Published by Springer Nature in World Journal of Emergency Surgery
Open AccessRun or Rush: a practical approach for diagnostic and therapeutic decision-making in patients with trauma and hemodynamic instability
- Open Access
- 17 November 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (11)
Association of Admission Dyskalemias With In‐Hospital Mortality in Patients Hospitalized for Heart Failure: Insights From the AMERICCAASS Registry
Background: Heart failure (HF) is a major global health concern, and dyskalemias are common and associated with adverse outcomes. However, evidence from the Americas, particularly Latin America and the Caribbean, remains limited. Objective: To evaluate the association between admission dyskalemias and in‐hospital mortality in hospitalized patients with HF across the Americas. Methods: This subanalysis of the AMERICCAASS Registry included hospitalized patients with HF with available admission serum potassium and documented discharge status. Patients were classified as hypokalemic (< 3.5 mmol/L), normokalemic (3.5–4.9 mmol/L), or hyperkalemic (≥ 5.0 mmol/L). In‐hospital mortality was assessed using Poisson regression and propensity score overlap weighting. Results: Among 1541 patients, 12.5% had hypokalemia, 75.6% normokalemia, and 11.9% hyperkalemia. Median age was 68 years, and 60.6% were male. Chronic kidney disease was more frequent in hyperkalemia (30.4%), whereas atrial fibrillation was more frequent in hypokalemia (30.7%). Dyskalemic patients more often presented with hypoperfusion profiles and higher New York Heart Association class. In the propensity score overlap‐weighted analysis, hyperkalemia was associated with higher in‐hospital mortality (aRR 1.81; 95% CI 1.10–2.97; p = 0.019), whereas no statistically significant association was detected for hypokalemia (aRR 1.43; 95% CI 0.79–2.60; p = 0.237). Conclusion: Admission hyperkalemia was associated with higher in‐hospital mortality among hospitalized patients with HF across the Americas. Given the observational design, hyperkalemia should be interpreted primarily as a marker of greater disease severity and short‐term clinical vulnerability rather than as a direct causal determinant of mortality.
- 17 November 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (11)
Open AccessAssociation of Admission Dyskalemias With In‐Hospital Mortality in Patients Hospitalized for Heart Failure: Insights From the AMERICCAASS Registry
Background: Heart failure (HF) is a major global health concern, and dyskalemias are common and associated with adverse outcomes. However, evidence from the Americas, particularly Latin America and the Caribbean, remains limited. Objective: To evaluate the association between admission dyskalemias and in‐hospital mortality in hospitalized patients with HF across the Americas. Methods: This subanalysis of the AMERICCAASS Registry included hospitalized patients with HF with available admission serum potassium and documented discharge status. Patients were classified as hypokalemic (< 3.5 mmol/L), normokalemic (3.5–4.9 mmol/L), or hyperkalemic (≥ 5.0 mmol/L). In‐hospital mortality was assessed using Poisson regression and propensity score overlap weighting. Results: Among 1541 patients, 12.5% had hypokalemia, 75.6% normokalemia, and 11.9% hyperkalemia. Median age was 68 years, and 60.6% were male. Chronic kidney disease was more frequent in hyperkalemia (30.4%), whereas atrial fibrillation was more frequent in hypokalemia (30.7%). Dyskalemic patients more often presented with hypoperfusion profiles and higher New York Heart Association class. In the propensity score overlap‐weighted analysis, hyperkalemia was associated with higher in‐hospital mortality (aRR 1.81; 95% CI 1.10–2.97; p = 0.019), whereas no statistically significant association was detected for hypokalemia (aRR 1.43; 95% CI 0.79–2.60; p = 0.237). Conclusion: Admission hyperkalemia was associated with higher in‐hospital mortality among hospitalized patients with HF across the Americas. Given the observational design, hyperkalemia should be interpreted primarily as a marker of greater disease severity and short‐term clinical vulnerability rather than as a direct causal determinant of mortality.
- Open Access
- 23 October 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
Availability of resources to apply the 2024 McDonald criteria: A global perspective
Background: The 3rd ECTRIMS Winter School highlighted regional and global disparities in resources needed to implement the 2024 McDonald diagnostic criteria for multiple sclerosis. Objectives: To assess the availability of paraclinical tools and regional differences in access reported by neurologists in an online survey. Results: The survey was completed by 328 neurologists from 44 countries. Core diagnostic tools, including magnetic resonance imaging and oligoclonal band testing, were widely available. Access to advanced imaging, optic nerve assessment, and laboratory biomarkers varied across regions. Conclusions: Variability in access to key paraclinical tests may impact on the implementation of the 2024 McDonald criteria globally.
- 23 October 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
Open AccessAvailability of resources to apply the 2024 McDonald criteria: A global perspective
Background: The 3rd ECTRIMS Winter School highlighted regional and global disparities in resources needed to implement the 2024 McDonald diagnostic criteria for multiple sclerosis. Objectives: To assess the availability of paraclinical tools and regional differences in access reported by neurologists in an online survey. Results: The survey was completed by 328 neurologists from 44 countries. Core diagnostic tools, including magnetic resonance imaging and oligoclonal band testing, were widely available. Access to advanced imaging, optic nerve assessment, and laboratory biomarkers varied across regions. Conclusions: Variability in access to key paraclinical tests may impact on the implementation of the 2024 McDonald criteria globally.
- Open Access
- 9 September 2026
- Published by Elsevier in SSRN Electronic Journal
From Aesthetic Procedures to Autoimmune Manifestations: First Comprehensive Characterization and Exploratory Clinical Phenotypic of Patients with Biopolymer Exposure from a Colombian Referral Center
Background: The growing popularity of nonsurgical aesthetic procedures, driven by beauty standards and access to affordable fillers, has promoted the widespread use of allogeneic substances such as biopolymers. These materials represent an emerging public health challenge in Latin American countries, particularly Colombia. Biopolymers have been associated with adjuvant-induced autoimmune/inflammatory syndrome (ASIA), yet the existing literature is limited and lacks clear consensus, creating a knowledge gap that hinders clinical management. Methods: A prospective longitudinal observational study was conducted in a high-complexity referral hospital in Colombia. Patients aged 18 years or older with biopolymer injection confirmed by MRI or extraction surgery were included (n = 83). Clinical, immunological, and imaging data were collected. Descriptive and inferential statistics were performed. An unsupervised cluster analysis using multiple correspondence analysis (MCA) and hierarchical clustering on principal components (HCPC) was conducted to identify clinical phenotypes. Results: Participants were predominantly women (97·6%), with a median age of 40 years. The buttocks were the most common application site (96·4%), and 72·3% of injections were administered by non-medical personnel. Three distinct clinical phenotypes were identified: a local inflammatory phenotype (Cluster 1, n=29, 35·4%), a low-burden heterogeneous phenotype (Cluster 2, n=40, 48·8%), and a systemic/sicca/autoimmune phenotype (Cluster 3, n=12, 14·6%). Overall, 33·7% had positive ANA, 18.1% had cryoglobulins, and 13·3% met at least one set of ASIA diagnostic criteria. Conclusion: This study provides the first comprehensive clinical characterization of patients with biopolymer exposure in Colombia and identifies three distinct clinical phenotypes. The findings underscore the need for systematic rheumatological evaluation and evidence-based treatment guidelines.
- 9 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFrom Aesthetic Procedures to Autoimmune Manifestations: First Comprehensive Characterization and Exploratory Clinical Phenotypic of Patients with Biopolymer Exposure from a Colombian Referral Center
Background: The growing popularity of nonsurgical aesthetic procedures, driven by beauty standards and access to affordable fillers, has promoted the widespread use of allogeneic substances such as biopolymers. These materials represent an emerging public health challenge in Latin American countries, particularly Colombia. Biopolymers have been associated with adjuvant-induced autoimmune/inflammatory syndrome (ASIA), yet the existing literature is limited and lacks clear consensus, creating a knowledge gap that hinders clinical management. Methods: A prospective longitudinal observational study was conducted in a high-complexity referral hospital in Colombia. Patients aged 18 years or older with biopolymer injection confirmed by MRI or extraction surgery were included (n = 83). Clinical, immunological, and imaging data were collected. Descriptive and inferential statistics were performed. An unsupervised cluster analysis using multiple correspondence analysis (MCA) and hierarchical clustering on principal components (HCPC) was conducted to identify clinical phenotypes. Results: Participants were predominantly women (97·6%), with a median age of 40 years. The buttocks were the most common application site (96·4%), and 72·3% of injections were administered by non-medical personnel. Three distinct clinical phenotypes were identified: a local inflammatory phenotype (Cluster 1, n=29, 35·4%), a low-burden heterogeneous phenotype (Cluster 2, n=40, 48·8%), and a systemic/sicca/autoimmune phenotype (Cluster 3, n=12, 14·6%). Overall, 33·7% had positive ANA, 18.1% had cryoglobulins, and 13·3% met at least one set of ASIA diagnostic criteria. Conclusion: This study provides the first comprehensive clinical characterization of patients with biopolymer exposure in Colombia and identifies three distinct clinical phenotypes. The findings underscore the need for systematic rheumatological evaluation and evidence-based treatment guidelines.
- Open Access
- 1 July 2026
- Published by Wiley in Pulmonary Circulation
- Vol. 16 (3) , e70411
Clinical Outcomes of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Cohort Study From a Latin American Care Center
Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct subtype of pulmonary hypertension arising from persistent major pulmonary artery obstruction after pulmonary embolism. Pulmonary endarterectomy (PEA) remains the standard of care, but up to 40% of patients in European and US registries are inoperable; balloon pulmonary angioplasty (BPA) has emerged as a more accessible interventional modality for suitable patients. This retrospective single‐center cohort study evaluated functional improvement, hemodynamic response, and mortality in patients with CTEPH ineligible for PEA who underwent BPA at a Colombian institution (May 2022–October 2025). Risk was stratified using COMPERA 2.0. The primary outcome was improvement of at least one New York Heart Association (NYHA) functional class; secondary outcomes were change in mean pulmonary arterial pressure (mPAP) and all‐cause mortality during follow‐up. Of 33 patients (median age 63 years; 70% female), 5 (15.1%) were high risk at baseline, 16 (48.4%) intermediate‐high, 10 (30.3%) intermediate‐low, and 2 (6%) low risk. After BPA, 19 patients (58%) improved NYHA class (95% CI, 39.2%–74.5%), and mPAP fell from 60 (IQR 50–68) to 40 mmHg (IQR 37–48) after a median of three sessions (IQR 2–4) (mean paired reduction 14.05 mmHg, 95% credible interval 9.81–18.07; Hedges’ g = 1.22, 95% CI 0.77–1.66). Two deaths (6.0%) occurred, both in high‐risk patients. BPA improved NYHA class and pulmonary hemodynamics in severe, inoperable CTEPH, with a low complication rate despite advanced baseline disease. COMPERA 2.0 stratified baseline severity but did not predict the magnitude of hemodynamic response to BPA, consistent with the mechanical nature of the disease.
- 1 July 2026
- Published by Wiley in Pulmonary Circulation
- Vol. 16 (3) , e70411
Open AccessClinical Outcomes of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Cohort Study From a Latin American Care Center
Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct subtype of pulmonary hypertension arising from persistent major pulmonary artery obstruction after pulmonary embolism. Pulmonary endarterectomy (PEA) remains the standard of care, but up to 40% of patients in European and US registries are inoperable; balloon pulmonary angioplasty (BPA) has emerged as a more accessible interventional modality for suitable patients. This retrospective single‐center cohort study evaluated functional improvement, hemodynamic response, and mortality in patients with CTEPH ineligible for PEA who underwent BPA at a Colombian institution (May 2022–October 2025). Risk was stratified using COMPERA 2.0. The primary outcome was improvement of at least one New York Heart Association (NYHA) functional class; secondary outcomes were change in mean pulmonary arterial pressure (mPAP) and all‐cause mortality during follow‐up. Of 33 patients (median age 63 years; 70% female), 5 (15.1%) were high risk at baseline, 16 (48.4%) intermediate‐high, 10 (30.3%) intermediate‐low, and 2 (6%) low risk. After BPA, 19 patients (58%) improved NYHA class (95% CI, 39.2%–74.5%), and mPAP fell from 60 (IQR 50–68) to 40 mmHg (IQR 37–48) after a median of three sessions (IQR 2–4) (mean paired reduction 14.05 mmHg, 95% credible interval 9.81–18.07; Hedges’ g = 1.22, 95% CI 0.77–1.66). Two deaths (6.0%) occurred, both in high‐risk patients. BPA improved NYHA class and pulmonary hemodynamics in severe, inoperable CTEPH, with a low complication rate despite advanced baseline disease. COMPERA 2.0 stratified baseline severity but did not predict the magnitude of hemodynamic response to BPA, consistent with the mechanical nature of the disease.
- Open Access
- 5 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (9) , e046820
Comorbidity Clusters in Acute Heart Failure: Insights From the AMERICCAASS Registry
Background: Acute heart failure (HF) frequently coexists with multimorbidity. Comorbidity clusters have been associated with distinct clinical outcomes, but data from the Americas remain limited. We aimed to identify comorbidity clusters in patients with acute HF and assess their association with in‐hospital outcomes. Methods: This cohort study applied latent class analysis to patients from the AMERICCAASS Registry (Registro Americano de Insuficiencia Cardiaca Ambulatoria o Agudamente descompensada). Adjusted Poisson regression assessed in‐hospital mortality and intensive care unit (ICU) admission, and multivariable analysis identified independent predictors of ICU admission. Results: Among 1638 patients, 60.6% were men and the median age was 67.2 years. Hypertension (69.4%), smoking (40.3%), and coronary artery disease (33.8%) were common comorbidities. Cluster 1 (Young, n=828) included the youngest patients (median age 63.2 years) with the fewest comorbidities. Cluster 2 (Cardio‐Kidney‐Metabolic, n=512) represented the oldest group (median age 71.8 years) with the highest median body mass index (27.7 kg/m 2 ), the greatest proportion of HF with mildly reduced or preserved ejection fraction (44.7%), and a high comorbidity burden. Cluster 3 (“Ischemic,” n=298) was characterized by older patients (median age 70.2 years) with an exceptionally high prevalence of coronary artery disease (96.3%) and the greatest proportion of HF with reduced ejection fraction (61.4%). ICU admission risk was higher in Cluster 2 (adjusted risk ratio [aRR], 1.15 [95% CI, 1.03–1.27]; P =0.009) and Cluster 3 (aRR, 1.25 [95% CI, 1.12–1.39]; P <0.001), compared with Cluster 1. Severe valvular insufficiency, peripheral artery disease, dyslipidemia, cancer, acute coronary syndrome, anemia, and cardiogenic shock were associated with higher ICU admission risk. Conclusions: Patients with acute HF in the Americas exhibit distinct comorbidity patterns associated with different clinical profiles and ICU admission rates, which may inform risk stratification and management strategies. Registration: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT05295641.
- 5 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (9) , e046820
Open AccessComorbidity Clusters in Acute Heart Failure: Insights From the AMERICCAASS Registry
Background: Acute heart failure (HF) frequently coexists with multimorbidity. Comorbidity clusters have been associated with distinct clinical outcomes, but data from the Americas remain limited. We aimed to identify comorbidity clusters in patients with acute HF and assess their association with in‐hospital outcomes. Methods: This cohort study applied latent class analysis to patients from the AMERICCAASS Registry (Registro Americano de Insuficiencia Cardiaca Ambulatoria o Agudamente descompensada). Adjusted Poisson regression assessed in‐hospital mortality and intensive care unit (ICU) admission, and multivariable analysis identified independent predictors of ICU admission. Results: Among 1638 patients, 60.6% were men and the median age was 67.2 years. Hypertension (69.4%), smoking (40.3%), and coronary artery disease (33.8%) were common comorbidities. Cluster 1 (Young, n=828) included the youngest patients (median age 63.2 years) with the fewest comorbidities. Cluster 2 (Cardio‐Kidney‐Metabolic, n=512) represented the oldest group (median age 71.8 years) with the highest median body mass index (27.7 kg/m 2 ), the greatest proportion of HF with mildly reduced or preserved ejection fraction (44.7%), and a high comorbidity burden. Cluster 3 (“Ischemic,” n=298) was characterized by older patients (median age 70.2 years) with an exceptionally high prevalence of coronary artery disease (96.3%) and the greatest proportion of HF with reduced ejection fraction (61.4%). ICU admission risk was higher in Cluster 2 (adjusted risk ratio [aRR], 1.15 [95% CI, 1.03–1.27]; P =0.009) and Cluster 3 (aRR, 1.25 [95% CI, 1.12–1.39]; P <0.001), compared with Cluster 1. Severe valvular insufficiency, peripheral artery disease, dyslipidemia, cancer, acute coronary syndrome, anemia, and cardiogenic shock were associated with higher ICU admission risk. Conclusions: Patients with acute HF in the Americas exhibit distinct comorbidity patterns associated with different clinical profiles and ICU admission rates, which may inform risk stratification and management strategies. Registration: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT05295641.
- Open Access
- 14 January 2026
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 21 (1) , 7
Survival in Adult Patients Undergoing Heart Transplantation 1995–2024: A Report of the RETRAC Registry
Background: Heart transplantation (HT) remains the definitive treatment for advanced heart failure that is refractory to both medical and invasive therapies. Although global registries offer extensive data on survival outcomes, there is a relative paucity of information regarding HT outcomes in Latin America (LATAM), particularly in Colombia. Methods: This study analyzed adult patients who underwent HT between 1995 and 2024, using data obtained from an institutional HT registry (RETRAC) in Cali, Colombia. Survival outcomes were evaluated using Kaplan–Meier curves and Cox proportional hazards models. Results: We included 260 patients who underwent HT in this 29-year cohort from a LATAM country. The median age at transplantation was 51 years, and 77.7% were male. The primary etiologies were idiopathic/dilated cardiomyopathy (IDC) (41.3%), ischemic cardiomyopathy (IC) (27.0%), and valvular heart disease (VHC) (9.7%). The most prevalent comorbidities were hypertension (HTN) (48.3%), diabetes mellitus (DM) (18.9%), and chronic kidney disease (CKD) (13.1%). The overall median survival following HT was 7.4 years. One-year survival was 74.6% (n = 194), five-year survival was 56.9% (n = 147), and ten-year survival was 46.9% (n = 122). Survival differed significantly by age and sex, with patients aged <40 years demonstrating the highest median survival (8.4 years) and those aged ≥60 years the lowest (2.2 years) (p = 0.038). The 40- to 49-year age group exhibited the most pronounced reduction in survival; however, this effect was attenuated after adjustment. Among patients under 40 years, females had significantly higher mortality compared to males (p = 0.0078), with younger males exhibiting better survival. Additionally, patients transplanted between 2016 and 2020 had higher survival rates. CKD was identified as a significant independent risk factor for increased mortality (hazard ratio (HR) = 1.79; 95% CI: 1.15–2.79; p = 0.01). Conclusions: HT patients in Colombia exhibit demographic and clinical profiles comparable to global cohorts; however, they demonstrate lower survival rates and poorer clinical outcomes compared to international registries, such as the International Society for Heart and Lung Transplantation registry. Nonetheless, clinical outcomes are more favorable than those reported in other studies from the LATAM region. CKD emerged as a significant independent predictor of mortality. These findings highlight the need for region-specific strategies aimed at improving HT outcomes in LATAM.
- 14 January 2026
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 21 (1) , 7
Open AccessSurvival in Adult Patients Undergoing Heart Transplantation 1995–2024: A Report of the RETRAC Registry
Background: Heart transplantation (HT) remains the definitive treatment for advanced heart failure that is refractory to both medical and invasive therapies. Although global registries offer extensive data on survival outcomes, there is a relative paucity of information regarding HT outcomes in Latin America (LATAM), particularly in Colombia. Methods: This study analyzed adult patients who underwent HT between 1995 and 2024, using data obtained from an institutional HT registry (RETRAC) in Cali, Colombia. Survival outcomes were evaluated using Kaplan–Meier curves and Cox proportional hazards models. Results: We included 260 patients who underwent HT in this 29-year cohort from a LATAM country. The median age at transplantation was 51 years, and 77.7% were male. The primary etiologies were idiopathic/dilated cardiomyopathy (IDC) (41.3%), ischemic cardiomyopathy (IC) (27.0%), and valvular heart disease (VHC) (9.7%). The most prevalent comorbidities were hypertension (HTN) (48.3%), diabetes mellitus (DM) (18.9%), and chronic kidney disease (CKD) (13.1%). The overall median survival following HT was 7.4 years. One-year survival was 74.6% (n = 194), five-year survival was 56.9% (n = 147), and ten-year survival was 46.9% (n = 122). Survival differed significantly by age and sex, with patients aged <40 years demonstrating the highest median survival (8.4 years) and those aged ≥60 years the lowest (2.2 years) (p = 0.038). The 40- to 49-year age group exhibited the most pronounced reduction in survival; however, this effect was attenuated after adjustment. Among patients under 40 years, females had significantly higher mortality compared to males (p = 0.0078), with younger males exhibiting better survival. Additionally, patients transplanted between 2016 and 2020 had higher survival rates. CKD was identified as a significant independent risk factor for increased mortality (hazard ratio (HR) = 1.79; 95% CI: 1.15–2.79; p = 0.01). Conclusions: HT patients in Colombia exhibit demographic and clinical profiles comparable to global cohorts; however, they demonstrate lower survival rates and poorer clinical outcomes compared to international registries, such as the International Society for Heart and Lung Transplantation registry. Nonetheless, clinical outcomes are more favorable than those reported in other studies from the LATAM region. CKD emerged as a significant independent predictor of mortality. These findings highlight the need for region-specific strategies aimed at improving HT outcomes in LATAM.
- Open Access
- 3 January 2025
- Published by Asociación Colombiana de Cirugía in Revista Colombiana de Cirugía
- Vol. 40 (1) , 121-130
Sutura innovadora en la preservación del páncreas en pacientes con trauma severo
Introducción. El tratamiento del trauma pancreático severo suele ser la resección quirúrgica; sin embargo, preservar el órgano debería ser una prioridad. El objetivo de este estudio fue proponer un enfoque innovador con sutura continua cruzada de las heridas transfixiantes del páncreas y describir los desenlaces tempranos de los pacientes tratados en un centro de trauma nivel I de atención. Métodos. Estudio descriptivo de pacientes con trauma pancreático tratados con cirugía en nuestra institución entre 2012 y 2022. Se analizaron las características clínicas, severidad según la clasificación AAST, desenlaces clínicos y mortalidad. Resultados. Se incluyeron 107 pacientes, 84 % hombres, con mediana de edad de 25 años (RIC 19-32) y puntaje ISS de 25 (RIC 13-41). El 82 % (n=89) presentaron trauma penetrante. Las lesiones pancreáticas fueron grado I en 32 (30 %) pacientes, grado II en 43 (40 %), grado III en 28 (26 %), grado IV en 3 (3 %) y grado V en 1 (1 %). Se hizo sutura primaria en 44 (41 %) pacientes y pancreatectomía en 15 (14 %). La incidencia de fístula postoperatoria entre los pacientes tratados con sutura fue de 33,3 % (n=4) y con pancreatectomía de 43 % (n=6). Un paciente con pancreatectomía presentó diabetes al alta (1 %). La mortalidad intrahospitalaria fue del 10,2 % (n=11). Conclusión. El manejo del trauma pancreático con sutura primaria es una opción viable y segura. En nuestra cohorte se preservó el órgano en casi la mitad de los pacientes con lesiones severas, sin aumentar el porcentaje de fístula.
- 3 January 2025
- Published by Asociación Colombiana de Cirugía in Revista Colombiana de Cirugía
- Vol. 40 (1) , 121-130
Open AccessSutura innovadora en la preservación del páncreas en pacientes con trauma severo
Introducción. El tratamiento del trauma pancreático severo suele ser la resección quirúrgica; sin embargo, preservar el órgano debería ser una prioridad. El objetivo de este estudio fue proponer un enfoque innovador con sutura continua cruzada de las heridas transfixiantes del páncreas y describir los desenlaces tempranos de los pacientes tratados en un centro de trauma nivel I de atención. Métodos. Estudio descriptivo de pacientes con trauma pancreático tratados con cirugía en nuestra institución entre 2012 y 2022. Se analizaron las características clínicas, severidad según la clasificación AAST, desenlaces clínicos y mortalidad. Resultados. Se incluyeron 107 pacientes, 84 % hombres, con mediana de edad de 25 años (RIC 19-32) y puntaje ISS de 25 (RIC 13-41). El 82 % (n=89) presentaron trauma penetrante. Las lesiones pancreáticas fueron grado I en 32 (30 %) pacientes, grado II en 43 (40 %), grado III en 28 (26 %), grado IV en 3 (3 %) y grado V en 1 (1 %). Se hizo sutura primaria en 44 (41 %) pacientes y pancreatectomía en 15 (14 %). La incidencia de fístula postoperatoria entre los pacientes tratados con sutura fue de 33,3 % (n=4) y con pancreatectomía de 43 % (n=6). Un paciente con pancreatectomía presentó diabetes al alta (1 %). La mortalidad intrahospitalaria fue del 10,2 % (n=11). Conclusión. El manejo del trauma pancreático con sutura primaria es una opción viable y segura. En nuestra cohorte se preservó el órgano en casi la mitad de los pacientes con lesiones severas, sin aumentar el porcentaje de fístula.
- Open Access
- 6 November 2024
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 44 (4) , 486-495
Concordance between clinical diagnoses and autopsies anatomopathological findings at a tertiary-level university hospital
Introduction. A clinical autopsy is a fundamental diagnostic tool for confirming the diagnosis of diseases of public health interest. However, the clinical-pathological concordance has not been evaluated.Objective. To determine the concordance between clinical diagnoses and anatomopathological findings from autopsies conducted at a tertiary-level hospital institution.Materials and methods. A descriptive, observational, cross-sectional, and retrospective study where we analyzed autopsy cases performed between 2015 and 2019. The variables studied were age, gender, origin, and clinical and anatomopathological diagnoses. Results. The concordance degree was slight (κ = 0.30; 95% CI: 0.21-0.42), which coincides with internationally reported findings in healthcare institutions with a similar patient population and availability of diagnostic resources. The clinical-pathological discrepancy, as evidenced according to the Goldman et al. classification, then modified by Battle et al., was 57.3% (47/82), corresponding to major discrepancies, a value within the expected limits.Conclusions. The concordance between clinical diagnoses and anatomopathological findings in autopsies is slight, and the discrepancies are within the expected range. This study highlights the importance of improving clinical and syndromic diagnosis of public health interest.
- 6 November 2024
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 44 (4) , 486-495
Open AccessConcordance between clinical diagnoses and autopsies anatomopathological findings at a tertiary-level university hospital
Introduction. A clinical autopsy is a fundamental diagnostic tool for confirming the diagnosis of diseases of public health interest. However, the clinical-pathological concordance has not been evaluated.Objective. To determine the concordance between clinical diagnoses and anatomopathological findings from autopsies conducted at a tertiary-level hospital institution.Materials and methods. A descriptive, observational, cross-sectional, and retrospective study where we analyzed autopsy cases performed between 2015 and 2019. The variables studied were age, gender, origin, and clinical and anatomopathological diagnoses. Results. The concordance degree was slight (κ = 0.30; 95% CI: 0.21-0.42), which coincides with internationally reported findings in healthcare institutions with a similar patient population and availability of diagnostic resources. The clinical-pathological discrepancy, as evidenced according to the Goldman et al. classification, then modified by Battle et al., was 57.3% (47/82), corresponding to major discrepancies, a value within the expected limits.Conclusions. The concordance between clinical diagnoses and anatomopathological findings in autopsies is slight, and the discrepancies are within the expected range. This study highlights the importance of improving clinical and syndromic diagnosis of public health interest.
- Open Access
- 11 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Evaluating the Shock Index, Revised Assessment of Bleeding and Transfusion (RABT), Assessment of Blood Consumption (ABC) and novel PTTrauma score to predict critical transfusion threshold (CAT) in penetrating thoracic trauma
The shock index (SI) has been associated with predicting transfusion needs in trauma patients. However, its utility in penetrating thoracic trauma (PTTrauma) for predicting the Critical Administration Threshold (CAT) has not been well-studied. This study aimed to evaluate the prognostic value of SI in predicting CAT in PTTrauma patients and compare its performance with the Assessment of Blood Consumption (ABC) and Revised Assessment of Bleeding and Transfusion (RABT) scores. We conducted a prognostic type 2, single-center retrospective observational cohort study on patients with PTTrauma and an Injury Severity Score (ISS) > 9. The primary exposure was SI at admission, and the primary outcome was CAT. Logistic regression and decision curve analysis were used to assess the predictive performance of SI and the PTTrauma score, a novel model incorporating clinical variables. Of the 620 participants, 53 (8.5%) had more than one CAT. An SI > 0.9 was associated with CAT (adjusted OR 4.89, 95% CI 1.64–14.60). The PTTrauma score outperformed SI, ABC, and RABT scores in predicting CAT (AUC 0.867, 95% CI 0.826–0.908). SI is a valuable predictor of CAT in PTTrauma patients. The novel PTTrauma score demonstrates superior performance compared to existing scores, highlighting the importance of developing targeted predictive models for specific injury patterns. These findings can guide clinical decision-making and resource allocation in the management of PTTrauma.
- 11 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Open AccessEvaluating the Shock Index, Revised Assessment of Bleeding and Transfusion (RABT), Assessment of Blood Consumption (ABC) and novel PTTrauma score to predict critical transfusion threshold (CAT) in penetrating thoracic trauma
The shock index (SI) has been associated with predicting transfusion needs in trauma patients. However, its utility in penetrating thoracic trauma (PTTrauma) for predicting the Critical Administration Threshold (CAT) has not been well-studied. This study aimed to evaluate the prognostic value of SI in predicting CAT in PTTrauma patients and compare its performance with the Assessment of Blood Consumption (ABC) and Revised Assessment of Bleeding and Transfusion (RABT) scores. We conducted a prognostic type 2, single-center retrospective observational cohort study on patients with PTTrauma and an Injury Severity Score (ISS) > 9. The primary exposure was SI at admission, and the primary outcome was CAT. Logistic regression and decision curve analysis were used to assess the predictive performance of SI and the PTTrauma score, a novel model incorporating clinical variables. Of the 620 participants, 53 (8.5%) had more than one CAT. An SI > 0.9 was associated with CAT (adjusted OR 4.89, 95% CI 1.64–14.60). The PTTrauma score outperformed SI, ABC, and RABT scores in predicting CAT (AUC 0.867, 95% CI 0.826–0.908). SI is a valuable predictor of CAT in PTTrauma patients. The novel PTTrauma score demonstrates superior performance compared to existing scores, highlighting the importance of developing targeted predictive models for specific injury patterns. These findings can guide clinical decision-making and resource allocation in the management of PTTrauma.